Company CVAbout Rekvina Labs Ltd 
Rekvina Labs Ltd
Micro Cap
Pharmaceuticals & Drugs
Rekvina Labs Limited was incorporated on 1st November 1988. From a small domestic company at inception in middle of 80's, Rekvina has grown formidably to be an integrated, Indian pharmaceutical company with sales in excess of Rs 20 Crore. It is registered in England and Wales as a Public Limited Company. The Company is a Quality producer of Pharmaceutical formulations for its customer as per their specific requirements. It provide contract research and manufacturing services to customers.
Company Coordinates
Company Details
328 Paradise Complex, Sayajigunj Vadodara Gujarat : 390005
Registrar Details
Purva Shareregistry (India) Pvt Ltd , Gala No 9, Shiv Shakti, Industrial Estate,Sitaram Mill Comp., J R Boricha Marg, Lower Parel [E], Mumbai
Capital StructureCapital Structure
Present Equity Capital
INR 3.01 Cr
Number of Shares
60.28 Cr
Face Value
INR 5.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
30-Apr-2014
60.28
3.01
3014000
5
Stock Split
30-Apr-2014
60.28
3.01
3014000
5
Stock Split
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Non Institution
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
Surbhit Mukesh Shah (15.22%)
Highest Public shareholder
Viralkumar Tribhovandas Patel (4.388%)
Individual Investors Holdings
51.98%
Board of Directors
Management
Designation
Remuneration
Amit Shah
Director
0
Mukesh Shah
Director
0
Vibha Mukesh Shah
Additional Director
0
Mahendra Shantilal Dalal
Additional Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
No Data Available for Finished Goods Segmentation
No Data Available
Stock DNARevenue and Profits:
Net Sales:
0 Cr
(Quarterly Results - Dec 2025)
Net Profit:
0 Cr
Pharmaceuticals & Drugs
INR 13 Cr (Micro Cap)
NA (Loss Making)
33
0.00%
-0.02
-25.10%
13.19
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
